パートナー
特許権利化、権利行使、抗弁で25年以上の経験を持つ。中心業務は特許訴訟、特許カウンセリング、及び米国特許商標庁(USPTO)での特許当事者系手続。米国連邦地方裁判所、連邦巡回控訴裁判所での控訴審、国際貿易委員会(ITC)での米国関税法337条手続、USPTOでの特許当事者系手続、等を主席弁護士として担当。
これまで20件以上のUSPTO特許審判部(PTAB)特許当事者系手続を主席弁護士として手掛ける。特許性及び発明優先権に関する特許当事者系手続に加え、特許インターフェアレンスを定める特許法291条に基づくUSPTO審判部の決定及び地裁申立案件をレビューする、特許法146条の地裁訴訟でも主席弁護士を務める。また、USPTO特許付与後レビュー手続、地裁訴訟、ITCの戦略的相互作用をテーマに世界各地で講演を行なう。
Intellectual Asset Management誌でワシントンD.C.エリアにおける一流の特許訴訟弁護士として選出。また、米国内で付与後レビュー手続を扱う一流の弁護士として評価された。網羅する技術分野は幅広く、コンピューター、ソフトウェア、半導体、医療機器、化学、製薬など多岐に亘る。
戦略的権利化手続、有効性及び侵害の鑑定書作成、特許ポートフォリオ管理、訴訟戦略、等幅広い分野でカウンセリングサービスを提供。クライアントの事業目標に沿った戦略構築を提案しており、新規技術領域で特許ポートフォリオを確立するにあたっての助言、IPランドスケープを考慮した知財戦略で取るべきポジションの立案、技術の買収やライセンスについての助言、攻撃的・防衛的訴訟戦略の立案等、を含む。また、ロースクール生への講義を数多く担当。USPTO特許当事者系手続に関する弁理士向け講義も手掛ける。
3年間弊所のマネージング・パートナーを務めた後、弊所のチェアマンを務めた。
Home Diagnostics, Inc. v. LifeScan, Inc.
Represented Home Diagnostics in a patent litigation concerning blood glucose meters; securing judgments of noninfringement from two district courts, which were affirmed on appeal.
5:99-cv-21269; 5:01-cv-20725, N.D. Cal., Judges Ware, Trumbull, Seeborg
01-1428, 03-1370, Fed. Cir., Judges Rader, Dyk, Prost, Mayer, Michel
Vas-Cath, Inc. v. University of Missouri
Represented the University of Missouri in a patent interference related to hemodialysis catheters before the USPTO, two district courts, and the Federal Circuit; judgment of priority was awarded in favor of the client and against Vas-Cath.
Int. No. 103988, Board of Patent Appeals and Interferences, Judge Martin
1:03-cv-01952, D.D.C., Judge Stafford
2:05-cv-00400, W.D. Mo., Judge Fenner
06-1100, Fed. Cir., Judges Newman, Lourie, Rader
Int. No. 105711, Board of Patent Appeals and Interferences, Judge Lee
Int. No. 105,700, Board of Patent Appeals and Interferences, Judge Lee
Certain Pesticides and Products Containing Clothianidin
337-TA-635, ITC, Judge Bullock
Roche Diagnostics Corp. v. Home Diagnostics Inc.
1:04-cv-00358, S.D. Ind., Judges McKinney, Shields
Prosecution First Blog
Junior Party Agilent Wins Interference with Sufficiently Corroborated Evidence of Priority of Invention Junior Party Agilent Wins Interference with Sufficiently Corroborated Evidence of Priority of Invention
February 17, 2023
Prosecution First Blog
Estoppel Halts Repeat Examination Estoppel Halts Repeat Examination
February 10, 2023
At the PTAB Blog
No Interference Estoppel to Zynga's IPR Petition No Interference Estoppel to Zynga's IPR Petition
October 7, 2022
At the PTAB Blog
Written Description Support Pre-AIA Scuttles PGR Written Description Support Pre-AIA Scuttles PGR
October 6, 2022
“Barbara McCurdy…[features] on the national table of the top post-grant experts…McCurdy doesn't play games, but is a grounded adviser with an admirable ability to carefully think through difficult issues and present creative solutions.”
Intellectual Asset Management Patent 1000
“Also highly rated is Barbara Clarke McCurdy, who practises with the utmost integrity, peers acknowledge: ‘She’s always straight with her opponents—judges see this and appreciate it.’ Like many here, McCurdy is a versatile operator capable of emerging victorious from battle in any forum.”
Intellectual Asset Management Patent 100
“McCurdy can ‘triage issues effectively as a result of her diverse expertise.’”
Intellectual Asset Management Patent 1000
“Barbara McCurdy…[features] on the national table of the top post-grant experts…McCurdy doesn't play games, but is a grounded adviser with an admirable ability to carefully think through difficult issues and present creative solutions.”
Intellectual Asset Management Patent 1000
“Also highly rated is Barbara Clarke McCurdy, who practises with the utmost integrity, peers acknowledge: ‘She’s always straight with her opponents—judges see this and appreciate it.’ Like many here, McCurdy is a versatile operator capable of emerging victorious from battle in any forum.”
Intellectual Asset Management Patent 100
“McCurdy can ‘triage issues effectively as a result of her diverse expertise.’”
Intellectual Asset Management Patent 1000
Press Release
32 Finnegan Attorneys Recognized by Best Lawyers 32 Finnegan Attorneys Recognized by Best Lawyers
August 17, 2023
Best LawyersPress Release
29 Finnegan Attorneys Ranked by Best Lawyers 29 Finnegan Attorneys Ranked by Best Lawyers
August 18, 2022
U.S. News—Best LawyersCommentary
Fed. Circ. Clamps Down on Post-IPR Invalidity Arguments Fed. Circ. Clamps Down on Post-IPR Invalidity Arguments
February 11, 2022
Law360Commentary
More Than Fintiv: What to Know About the PTAB Revision Bill More Than Fintiv: What to Know About the PTAB Revision Bill
October 1, 2021
Law360Media Mention
Biogen MS Drug Patent Survives Mylan's PTAB Challenge Biogen MS Drug Patent Survives Mylan's PTAB Challenge
February 6, 2020
Law360Media Mention
Biogen Prevails in Fed. Circ. MS Drug Dispute with Forward Biogen Prevails in Fed. Circ. MS Drug Dispute with Forward
October 24, 2018
Law360Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.